Immunosuppressive therapy with rituximab in common variable immunodeficiency

Common variable immunodeficiency (CVID) is the most frequent symptomatic primary antibody deficiency in adulthood and is characterized by the marked reduction of IgG and IgA serum levels. Thanks to the successful use of polyvalent immunoglobulin replacement therapy to treat and prevent recurrent inf...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:Clin Mol Allergy
Autori principali: Pecoraro, Antonio, Crescenzi, Ludovica, Galdiero, Maria Rosaria, Marone, Giancarlo, Rivellese, Felice, Rossi, Francesca Wanda, de Paulis, Amato, Genovese, Arturo, Spadaro, Giuseppe
Natura: Artigo
Lingua:Inglês
Pubblicazione: BioMed Central 2019
Soggetti:
Review
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC6501382/
https://ncbi.nlm.nih.gov/pubmed/31080365
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12948-019-0113-3
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi